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YcdB is a periplasmic haem-containing protein from Escherichia coli that has a
potential role in iron transport. It is currently the only reported haem-containing
Tat-secreted substrate. Here, the overexpression, puriﬁcation, crystallization
and structure determination at 2.0 A ˚ resolution are reported for the apo form of
the protein. The apo-YcdB structure resembles those of members of the haem-
dependent peroxidase family and thus conﬁrms that YcdB is also a member of
this family. Haem-soaking experiments with preformed apo-YcdB crystals have
been optimized to successfully generate haem-containing YcdB crystals that
diffract to 2.9 A ˚ . Completion of model building and structure reﬁnement are
under way.
1. Introduction
Although the vast majority of organisms are absolutely dependent on
iron, acquisition of sufﬁcient quantities of this metal is often chal-
lenging owing to its poor solubility and potential toxicity (Andrews et
al., 2003). Competition for iron resources is particularly acute for
pathogenic bacteria, which must overcome the iron-withdrawal
strategies of their hosts in order to satisfy their iron requirements
(Litwin & Calderwood, 1993). Bacteria generally overcome iron
restriction by utilizing a number of alternative iron transporters that
enable them to scavenge iron from various sources. The most
common type of iron-uptake strategy employed by bacteria involves
the secretion and/or utilization of high-afﬁnity iron chelators, known
as siderophores, which bind and solubilize ferric iron. In Gram-
negative bacteria, ferri-siderophore complexes are taken up via an
outer-membrane (OM) receptor and binding-protein-dependent
ABC inner-membrane system requiring the energy-transducing
TonB–ExbBD complex for translocation across the OM. Related
systems are used by pathogens to directly obtain iron from host iron-
containing proteins. Often, bacteria contain multiple ferric complex-
uptake systems enabling them to piratize siderophores produced by
other organisms. Bacteria can also acquire the soluble ferrous form of
iron via the FeoAB pathway, NRAMP-like transporters (e.g. MntH)
or through metal-type ABC transporters (e.g. SitABCD) (Andrews et
al., 2003).
Recent evidence suggests that bacteria possess another major
route for iron uptake that resembles the high-afﬁnity iron-transport
system of yeast and other fungi. In yeast, this pathway consists of
three plasma-membrane components: Frt1p, a polytopic ferrous
permease, Fet3p, an Frtp1-associated multicopper oxidase that
oxidizes ferrous iron to the ferric form during the Ftr1p-mediated
uptake process, and Fre1p, one of several related ﬂavin- and haem-
containing NADPH-dependent ferric reductases that reduces extra-
cellular ferric iron to the ferrous form prior to transport via Ftr1p
(Kosman, 2003). In bacteria, genes encoding homologues of Ftr1p are
common, being found in proteobacteria, actinobacteria and ﬁrmi-
cutes, and are often adjacent to other iron-related genes (Woodhall,
2005; Debut et al., 2006). In Escherichia coli, the Ftr1p homologue
(YcdN) is part of an iron and Fur (ferrous uptake regulator)
repressed operon, ycdNOB (McHugh et al., 2003). In Bacillus subtilis
and Neisseria meningitides, the ycdNOB-like operons, ywbLMN and
NMB0034-36, respectively, are likewise iron-repressed (Baichoo et
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Ftr1p homology, is highly suggestive of an iron-transport role for
these YcdNOB-like systems. This supposition has been recently
conﬁrmed in B. subtilis by the ﬁnding that the YwbLMN system is
involved in the uptake of free ferric iron (Ollinger et al., 2006).
Recent studies on YcdNOB from E. coli strain Nissle 1917 suggest a
role in ferrous iron transport (Grosse et al., 2006). Interestingly, there
is evidence that the ycdNOB operon of E. coli is induced by low pH
(Stancik et al., 2002), conditions which favour ferric iron solubility
and ferrous iron stability against oxidation.
The speciﬁc roles of the ycdNOB-encoded YcdO and YcdB
proteins in YcdN-mediated iron uptake are unclear. YcdO is unlike
any other characterized protein in the sequence databases, but the
corresponding gene is found associated with ycdN and ycdB homo-
logues in all cases to date. YcdO possesses an N-terminal signal
sequence, suggesting that it is exported to the periplasm in a Sec-
dependent manner. YcdB is also periplasmic, but unlike YcdO it
contains b-type haem and is secreted via the twin-arginine transport
(Tat) pathway. Currently, it is the only known haem-containing Tat
substrate (Sturm et al., 2006). The B. subtilis YcdB homologue
(YwbN) has also been shown to be exported via the Tat system
(Jongbloed et al., 2004).
Signiﬁcantly, YcdB exhibits homology to the dye-decolorizing
peroxidase, DyP, of Thanatephorus cucumeris (previously called
Geotrichum candidum) Dec 1 (Kim & Shoda, 1999). The crystal
structure of DyP has recently been solved, revealing the presence of a
single haem b moiety within a cytochrome c peroxidase fold (Sato et
al., 2004). A low-pH-enhanced peroxidase activity has also been
reported for YcdB and, consistent with this, the ycdN homologue of
N. meningitides is induced by H2O2-mediated redox stress (Grifantini
et al., 2003, 2004; Sturm et al., 2006). However, it is unclear how these
ﬁndings relate to the proposed iron-transport function of YcdNOB.
In an effort to understand the role of these proteins in iron
transport and elucidate their mechanism of action, we have embarked
on X-ray structural studies of this novel iron-transport system in
E. coli. This work reports the overexpression, puriﬁcation, crystal-
lization and preliminary X-ray crystallographic analysis of the apo
form (haem-free) of YcdB of E. coli K-12 and recent progress
towards solving the structure of the haem-containing form.
2. Materials and methods
2.1. Cloning, expression and purification
The ycdB gene was PCR-ampliﬁed from E. coli K-12 genomic
DNA using Accuzyme (Bioline) and cloned into the overexpression
vector pET-46 Ek/LIC (Novagen) generating pET46-His6ycdB.T h e
cloning was performed such that the N-terminal Tat signal sequence
(residues 1–35) of YcdB was replaced by the His6 tag and entero-
kinase cleavage sequence (MAH6VD4KI) encoded by the over-
expression vector. Overexpression of ‘(His)6YcdB’ (43 kDa subunit
weight) was achieved using BL21/ DE3(pET46-His6ycdB) cultured
in L-broth with ampicillin (100 mgm l
 1) at 250 rev min
 1 and 310 K
and induced with 1 mM isopropyl  -d-thio-galactopyranoside
(IPTG) when the culture optical density at 650 nm reached 0.5. The
IPTG-induced cells were cultured for a further 16 h, harvested by
centrifugation for 20 min at 3000g and 277 K and resuspended in 3 ml
(per gram cell weight) buffer A (25 mM HEPES pH 7.4, 50 mM
imidazole, 0.2 M NaCl) before being lysed at 137 MPa using a French
press. (His)6YcdB was then puriﬁed from the soluble supernatant by
Ni
2+-afﬁnity chromatography (HiTrap Afﬁnity resin, Pharmacia)
using buffer A as the binding buffer and buffer B (buffer A plus 0.5 M
imidazole) for elution (Fig. 1a). Two major (His)6YcdB elution peaks
were obtained: the ﬁrst corresponded to cofactor-containing
(His)6YcdB, with the second corresponding to the apo form (Fig. 1b).
The resulting protein was >95% pure according to SDS–PAGE
analysis and was dialysed against 25 mM HEPES pH 7.4 prior to
storage at 193 K.
2.2. Crystallization
Puriﬁed apo-(His)6YcdB was concentrated to 10 mg ml
 1 in
25 mM HEPES buffer pH 7.4 using centrifugal membrane concen-
trators (Vivaspin). The ﬁnal concentration was determined using a
Bradford assay. Initial crystallization screening was performed
manually using the sitting-drop vapour-diffusion method in 24-well
Linbro plates against the following commercial screens at 291 K:
Structure Screens I and II, Macrosol I and II, Stura Footprint Screens
I and II (all from Molecular Dimensions Ltd) and Wizard I and II
(from Emerald BioSystems). The drop size was 2 mlp l u s2ml in all
cases.
From the 384 conditions screened, seven hits were found that
indicated two types of crystal morphology: feather-like needles
(Fig. 2a) and small bipyramidal crystals (Fig. 2b). Crystals typically
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Figure 1
Puriﬁcation of apo-(His)6YcdB. (a) SDS–PAGE (12% acrylamide) of samples at
different stages of apo-(His)6YcdB puriﬁcation from the (His)6YcdB over-
expressing strain. MWM, molecular-weight markers (kDa); lane 1, soluble crude
extract following cell lysis and centrifugation; lane 2, apo-(His)6YcdB after Ni
2+-
afﬁnity chromatography; lane 3, apo-(His)6YcdB following anion-exchange
chromatography. Approximately 50, 20 and 5 mg of protein were loaded in lanes
1, 2 and 3, respectively. (b) Elution proﬁle of overexpressed (His)6YcdB during
Ni
2+-afﬁnity chromatography. The concentration of imidazole applied to the
column is indicated, as are the elution peaks corresponding to the apo and holo
forms of (His)6YcdB.appeared between 14 and 28 d. The most promising lead was
Macrosol II No. 14 [1.5 M ammonium sulfate, 2%(v/v) PEG 400,
0.1 M HEPES pH 7.5], which gave single bipyramidal crystals with
typical dimensions of 0.1   0.1   0.15 mm.
Optimization, particularly of the pH, resulted in large single
crystals of typical dimensions of 0.2   0.2   0.3 mm (Fig. 2c). The
ﬁnal conditions for reproducible apo-(His)6YcdB crystal growth were
1.8–2.0 M ammonium sulfate, 2–8%(v/v) PEG 400, 0.1 M HEPES pH
7.0 at 291 K. These crystals were of suitable size and quality for X-ray
diffraction analysis. The optimized conditions yielded crystals within
14 d.
Initial attempts to cocrystallize apo-(His)6YcdB in the presence of
haem (stock solution of 100 mM bovine haemin, from Sigma–
Aldrich, in a mixture of 50 mM arginine and 50 mM glutamine) were
unsuccessful. However, the addition of small amounts of solid haemin
directly tothe hanging drops containing preformed colourless crystals
of apo-(His)6YcdB gave rise to red-coloured crystals after 1–2 d
(Fig. 2d).
2.3. Data collection and diffraction analysis
Prior to data collection, the apo-(His6)YcdB crystals were cryo-
protected in 25% PEG 550 MME by quick transfer directly from the
hanging drop. For the haem-soaked apo-(His)6YcdB crystals, opti-
mization of the cryoconditions was critically important in order to
eliminate major problems arising from phase separation, rapid crystal
decay and icing. The ﬁnal cryoconditions necessary for successful
freezing and data collection of haem-soaked apo-(His)6YcdB crystals
were a mixture of 0.75 M ammonium sulfate, 5 mM NaCl, 0.5 M
sodium formate, 6.4% PEG 400 and 2.5% glycerol in 0.1 M HEPES
pH 7.0.
Intensity data were collected on an ADSC Quantum 4 CCD
detector at 100 Kon the macromolecular beamline Station ID14-EH2
(ESRF, Grenoble, France). Fig. 3(a) shows a typical diffraction image
for apo-(His)6YcdB taken at ESRF. Data were collected to 2.0 A ˚
resolution. Data were integrated and scaled using the programs
MOSFLM v.6.2.4 (Leslie, 1992) and SCALA (Evans, 1997), respec-
tively, from the CCP4 program package (Collaborative Computa-
tional Project, Number 4, 1994). The apo-(His)6YcdB crystals
exhibited orthorhombic symmetry, space group P212121, with unit-cell
parameters a = 83.31, b = 86.26, c = 119.58 A ˚ , and two molecules in
the asymmetric unit. Data-processing statistics for apo-(His)6YcdB
are shown in Table 1.
Fig. 3(b) shows a diffraction image taken on the in-house source
(FR-D Rigaku/MSC, Cu K  radiation) of one of the best diffracting
crystals of haem-soaked apo-(His)6YcdB. Diffraction was observed to
2.9 A ˚ resolution. These crystals were also orthorhombic, space group
P212121, and showed minor changes in the unit-cell parameters:
a = 84.88, b = 87.76, c = 122.99 A ˚ . Haem-soaked apo-(His)6YcdB
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Table 1
Data-collection and processing statistics for apo-(His)6YcdB.
Values in parentheses are for the highest resolution shell.
Synchrotron beamline ESRF ID14-EH2
Wavelength (A ˚ ) 0.933
Space group P212121
Unit-cell parameters (A ˚ ) a = 83.31, b = 86.26, c = 119.58
Resolution range (A ˚ ) 50.0–2.0 (2.11–2.0)
Rmerge† 7.8 (24.1)
No. of observations 627643 (85466)
No. of unique reﬂections 58729 (8360)
Mean I/ (I)‡ 26.5 (8.0)
Completeness (%) 99.7 (98.8)
Multiplicity 10.7 (10.2)
Solvent content (%) 41
Molecules per ASU 2
† Rmerge =
P
h
P
i jIh;i  h Ihij=
P
h
P
i jIh;ij, where the outer summation is over all unique
reﬂections with multiple observations and the inner summation is over all observations of
each reﬂection. ‡  (I) is the standard deviation of I.
Figure 2
Crystallization of apo-(His)6YcdB from E. coli.( a) Feather-like needles observed from initial screening, Macrosol I No. 22; (b) bipyramidal crystals observed from initial
screening, Macrosol II No. 14; (c) optimized conditions from (b), 2 M ammonium sulfate, 5% PEG 400, 0.1 M HEPES pH 7.0; (d) solid haem soaked into preformed apo-
(His)6YcdB optimized crystals. The drop size was 2 mlp l u s2ml and the protein concentration was 10 mg ml
 1 in all cases.crystals exhibited high mosaicity (>1 ) and anisotropy and showed
signs of crystal splitting.
2.4. Phasing
The protein for which a structure had been reported that shared
the highest amino-acid sequence homology (25% over 183 residues,
determined using WU-Blast2) was found to be DyP, a dye-colourizing
peroxidase from T. cucumeris. No coordinates were available for DyP
(Sato et al., 2004); however, two distant fungal homologues to DyP
were present in the Protein Data Bank: lignin peroxidase (LiP) and
manganese peroxidase (MnP). The two fungal peroxidases shared
less than 10% overall sequence identity with YcdB. The program
CHAINSAW (Schwarzenbacher et al., 2004) was used to align the
target sequence (YcdB) and the two model sequences from LiP (PDB
code 1lga) and MnP (PDB code 1mnp) such that all the atoms
common to the three models were retained. The resulting model,
consisting of residues 34–291 (of a total of 423 residues) of the
(His)6YcdB sequence, was used as the search model for molecular
replacement against all data between 50 and 3.0 A ˚ using MOLREP
(Vagin & Teplyakov, 1997). The program DM (Cowtan & Main, 1996)
was used for noncrystallographic symmetry (NCS) averaging and
solvent ﬂattening of the electron-density map, which clearly showed
distinguishable secondary-structural features (Fig. 4). Model building
and reﬁnement are in progress using the programs Coot (Emsley &
Cowtan, 2004) and REFMAC (Murshudov et al., 1997), respectively.
3. Conclusion
The gene encoding YcdB from E. coli was cloned from genomic DNA
and overexpressed using a T7 promoter-based vector and the apo
form of (His)6YcdB was puriﬁed by Ni
2+-afﬁnity chromatography.
Crystals of apo-(His)6YcdB were produced and conditions were
found for the generation of a potential haem-containing derivative
using preformed apo-(His)6YcdB crystals. Diffraction-quality crystals
were obtained in each case through careful optimization of pH and
cryoprotecting conditions, which gave reproducible crystals that
crystallization communications
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Figure 3
(a) Typical diffraction image from apo-(His)6YcdB crystals obtained at ESRF ID14-EH2. (b) The best diffraction image from haem-soaked apo-(His)6YcdB crystals
obtained using the in-house X-ray source (Rigaku/MSC FR-D, Cu K  radiation).
Figure 4
Electron-density map of apo-(His)6YcdB at 2.0 A ˚ resolution contoured at 1  in the
region of residues 130–150, a well conserved surface loop. Model building and
reﬁnement are in progress. The initial model covers the region between residues 34
and 291 (of 423 residues).diffracted to 2.0 A ˚ for apo-(His)6YcdB and more typically to 2.9 A ˚
for the haem-soaked derivative. Much of the success in obtaining
suitable diffraction from haem-soaked apo-(His)6YcdB was achieved
by careful optimization of the cryoprotectant (0.75 M ammonium
sulfate, 5 mM NaCl, 0.5 M sodium formate, 6.4% PEG 400 and 2.5%
glycerol in 0.1 M HEPES pH 7.0) in order to eliminate serious
problems arising from phase separation and rapid crystal decay.
However, numerous haem-soaked apo-(His)6YcdB crystals were
tested and many exhibited high mosaicity (>1 ) and showed signs of
anisotropy and crystal splitting, making integration and scaling
difﬁcult. Efforts are under way to crystallize holo-(His)6YcdB, since a
crucial aspect of this work is to determine the role of this protein in
iron transport and as such the location and the surrounding envir-
onment of the haem are critically important.
With regard to the haem environment, it has been shown that
although the proximal histidine exhibits structural similarity, there
are noted differences in the haem environment between the related
peroxidases currently known, i.e. between DyP and both LiP and
MnP. DyP has been reported to contain a four-stranded antiparallel
 -sheet distal to the haem ligand, a structural feature which is not
present in either LiP or MnP (Sato et al., 2004). The nature of this
structural difference is presently unknown. Completion of model
building and reﬁnement will reveal the extent of the structural
similarity between YcdB from E. coli and other structurally deﬁned
members of the superfamily of haem-dependent peroxidases.
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